Pierre Youinou

Brest, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 60 publications

Uric acid increases IL-1β secretion and Caspase-1 activation in PBMCs of Behçet's disease patients: The in vitro immunomodulatory effect of xanthine oxidase inhibitor Allopurinol.

Uric acid increases IL-1β secretion and Caspase-1 activation in PBMCs of Behçet's disease patients: The in vitro immunomodulatory effect of xanthine oxidase inhibitor Allopurinol.

Journal: International immunopharmacology

Published: November 15, 2019

Increased IL-1β levels are associated with an imbalance of "oxidant/antioxidant" status during Behçet's disease.

Increased IL-1β levels are associated with an imbalance of "oxidant/antioxidant" status during Behçet's disease.

Journal: European cytokine network

Published: December 15, 2018

Interferon-β inhibits inflammatory responses mediators via suppression of iNOS signaling pathway in PBMCs from patients with primary Sjögren's syndrome.

Interferon-β inhibits inflammatory responses mediators via suppression of iNOS signaling pathway in PBMCs from patients with primary Sjögren's syndrome.

Journal: Inflammopharmacology

Published: April 07, 2018

Cardamonin inhibits pro-inflammatory cytokine production and suppresses NO pathway in PBMCs from patients with primary Sjögren's syndrome.

Cardamonin inhibits pro-inflammatory cytokine production and suppresses NO pathway in PBMCs from patients with primary Sjögren's syndrome.

Journal: Immunopharmacology and immunotoxicology

Published: January 06, 2018

A case for IL-6, IL-17A, and nitric oxide in the pathophysiology of Sjögren's syndrome.

A case for IL-6, IL-17A, and nitric oxide in the pathophysiology of Sjögren's syndrome.

Journal: International journal of immunopathology and pharmacology

Published: February 02, 2016

CD5 expression promotes IL-10 production through activation of the MAPK/Erk pathway and upregulation of TRPC1 channels in B lymphocytes.

CD5 expression promotes IL-10 production through activation of the MAPK/Erk pathway and upregulation of TRPC1 channels in B lymphocytes.

Journal: Cellular & molecular immunology

Published: January 21, 2016

Human regulatory B cells control the TFH cell response.

Human regulatory B cells control the TFH cell response.

Journal: The Journal of allergy and clinical immunology

Published: February 24, 2015

Anti-alpha-actinin antibodies are part of the anti-cell membrane antibody spectrum that characterize patients with lupus nephritis.

Anti-alpha-actinin antibodies are part of the anti-cell membrane antibody spectrum that characterize patients with lupus nephritis.

Journal: Journal of autoimmunity

Published: October 21, 2014

Primary Sjögren's syndrome at a glance today.

Primary Sjögren's syndrome at a glance today.

Journal: Joint bone spine

Published: September 10, 2014

Cytokines Modulate the "Immune-Metabolism" Interactions during Behçet Disease: Effect on Arginine Metabolism.

Cytokines Modulate the "Immune-Metabolism" Interactions during Behçet Disease: Effect on Arginine Metabolism.

Journal: International journal of inflammation

Published: June 13, 2014

TLR9 expressed on plasma membrane acts as a negative regulator of human B cell response.

TLR9 expressed on plasma membrane acts as a negative regulator of human B cell response.

Journal: Journal of autoimmunity

Published: February 04, 2014

Specific forms of BAFF favor BAFF receptor-mediated epithelial cell survival.

Specific forms of BAFF favor BAFF receptor-mediated epithelial cell survival.

Journal: Journal of autoimmunity

Published: February 04, 2014

Showing 1-12 of 60

Last Updated: 09/26/2026